News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Celgene (CELG) Decides to Not Move Forward With Phase III Portion of tnAcity     12/7/2016
NICE U-Turns and Backs Approval of Roche (RHHBY)'s Perjeta for HER2-Positive Breast Cancer     11/22/2016
Puma Biotech (PBYI) Crashes After Diarrhea Risk is Linked to Breast Cancer Drug in Abstract     11/16/2016
Eli Lilly (LLY)'s Breast Cancer Drug Failed to Meet Phase III Goals, But Panel Recommends Continuation of Trial     8/10/2016
FDA Bestows Novartis AG (NVS)'s Breast Cancer Pill With Breakthrough Tag     8/3/2016
Amgen (AMGN) And Allergan (AGN) Biosimilar Found as Effective as Genentech (RHHBY)'s Herceptin     7/21/2016
Galena Biopharma  (GALE) Craters and Discontinues Phase III Breast Cancer Vaccine NeuVax     6/30/2016
ASCO2016: Mylan (MYL)-BioCon (BIOCON.NS)'s Biosimilar Cancer Drug Comparable to Roche (RHHBY)'s Herceptin     6/6/2016
ASCO2016: Immunomedics (IMMU) Breast Cancer Abstract Booted from Conference     6/6/2016
Nektar Therapeutics (NKTR), DAIICHI SANKYO EUROPE GmbH Strike $80 Million+ ONZEALD Pact     6/1/2016
Novartis AG (NVS) Trial Stopped Early on Positive Data, Gets Ready to Take on Pfizer (PFE)'s Ibrance     5/31/2016
AstraZeneca PLC (AZN)'s Fulvestrant Meets Goals in Phase III Study     5/27/2016
SoCal's Puma Biotech (PBYI) Delays NDA for Neratinib to Treat Breast Cancer Until Mid-2016     3/29/2016
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015     3/24/2016
Breast Cancer Pipeline Has More than 1,000 Drugs in Development     3/9/2016

News from Around the Web
How 3 Huge Discoveries in 2016 are Moving Us Closer to a Breast Cancer Cure     10/24/2016
Puma Biotech (PBYI)'s $150 Million Stock Offering May Signal to Investors That Its Breast Cancer Drug is in Trouble     10/20/2016
Mammograms More Likely To Cause Unneeded Treatment Than To Save Lives, Published In BMJ     10/13/2016
Newly Developed: Non-Invasive, Safe Tester For Breast Cancer Diagnosis, Polish Biotech Braster Reveals     10/7/2016
Implant Improves Breast Cancer Survival, University of Michigan Study     9/30/2016
Want A BRCA Test? Some Insurers Require Genetic Counseling First     9/19/2016
Simple Blood Test Could Be Used To Detect Breast Cancer, University of Western Australia Study     9/9/2016
New Platform Hopes To Speed Diagnosis Of Parkinson's Disease And Breast Cancer, Oxford Impedance Diagnostics Reveals     8/1/2016
New Review Concludes Evidence For Alcohol Causing Cancer Is Strong, University Of Otago Study     7/22/2016
Got Dense Breasts? That Can Depend On Who Is Reading The Mammogram, University of Vermont Study     7/19/2016
Hops Extract Could Help Reduce Breast Cancer Risk, University of Illinois Study     7/12/2016
Why Do More Black Women Die of Breast Cancer? NIH Study     7/8/2016
NASA Technology Reveals Bacteria's Role In Breast Cancer     6/28/2016
In Mice, Daughters Of Overweight Dads Have Altered Breast Tissue, Higher Cancer Risk, Georgetown University Medical Center Study     6/27/2016
4 Things You Can Do To Decrease The Chance Your Breast Cancer Risk, Study Published In JAMA     6/3/2016

Press Releases
Eli Lilly (LLY) Presents neoMONARCH Phase 2 Data On Abemaciclib In Early-Stage Breast Cancer     12/8/2016
AstraZeneca PLC (AZN) Announces Subgroup Analysis From FALCON Trial Comparing FASLODEX (Fulvestrant) To ARIMIDEX (Anastrozole)     12/8/2016
Avelas Biosciences Presents Phase 1b Clinical Trial Data For AVB-620 At 2016 San Antonio Breast Cancer Symposium     12/8/2016
GTX Corp Reports Results From Ongoing Enobosarm Phase 2 Clinical Trial In ER+/AR+ Breast Cancer     12/8/2016
Puma Biotech (PBYI) Presents Results Of Biomarker Analysis Of Phase II Trial Of PB272 In Neoadjuvant Treatment Of HER2-Positive Locally Advanced Breast Cancer At The 2016 San Antonio Breast Cancer Symposium     12/8/2016
Puma Biotech (PBYI) Presents Interim Results Of Phase II Trial Of PB272 For ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer At The 2016 San Antonio Breast Cancer Symposium     12/8/2016
Puma Biotech (PBYI) Presents Interim Results Of Phase II CONTROL Trial Of PB272 In Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer At The 2016 San Antonio Breast Cancer Symposium     12/8/2016
Radius Health (RDUS) Presents Positive Phase I Data For Investigational Drug RAD1901 At The San Antonio Breast Cancer Symposium (SABCS) 2016     12/8/2016
The Breast Cancer Research Foundation Announces New Research Projects To Develop Treatments For Metastatic Breast Cancer     12/8/2016
bioTheranostics Release: New Data Substantiate The Ability Of Breast Cancer Index(SM) To Help Physicians Identify Early Stage ER+ Breast Cancer Patients For Extended Anti-Estrogen Therapy     12/8/2016
Clinical Utility Of Biocept, Inc. (BIOC)'s Liquid Biopsy Platform Demonstrated In Study Results Presented At The 2016 San Antonio Breast Cancer Symposium     12/8/2016
Endomagnetics Limited’s Sentimag And Sienna Demonstrated Non-Inferior To Standard Of Care For Sentinel Node Detection     12/8/2016
With a New Name and Leader, Cascadian Therapeutics (ONTY) Rejigs Breast Cancer Study to Meet FDA's Standards     12/7/2016
Cannabics Pharma Announces Specific Ratios Of Cannabinoids Led To Apoptosis In MDA-MB-231 Breast Cancer Cell Viability     12/1/2016
Eisai Company (ESALY.PK) Release: Halaven (Eribulin) Receives Registration In South Africa For Treatment Of Women With Advanced Breast Cancer     12/1/2016